Skip to main content

Peer Review reports

From: Optimal daratumumab-based regimen for patients with newly diagnosed and previously untreated multiple myeloma: systematic review and component network meta-analysis

Original Submission
18 Sep 2024 Submitted Original manuscript
12 Oct 2024 Reviewed Reviewer Report - DR. YAHYA H. Y. ALFARRA
15 Oct 2024 Reviewed Reviewer Report - Arturo J Martí-Carvajal
22 Oct 2024 Reviewed Reviewer Report - Jackline Ayres-Silva
24 Oct 2024 Reviewed Reviewer Report - Shailendra Maurya
22 Nov 2024 Author responded Author comments - Xiaohua Huang
Resubmission - Version 2
22 Nov 2024 Submitted Manuscript version 2
3 Jan 2025 Author responded Author comments - Xiaohua Huang
Resubmission - Version 3
3 Jan 2025 Submitted Manuscript version 3
15 Feb 2025 Author responded Author comments - Xiaohua Huang
Resubmission - Version 4
15 Feb 2025 Submitted Manuscript version 4
17 Feb 2025 Author responded Author comments - Xiaohua Huang
Resubmission - Version 5
17 Feb 2025 Submitted Manuscript version 5
Publishing
25 Feb 2025 Editorially accepted
16 May 2025 Article published 10.1186/s13643-025-02804-4

You can find further information about peer review here.

Back to article page